Atlas Trials

Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

Clinical trial NCT04815850 · COMPLETED

Trial details

NCT number
NCT04815850
Sponsor
University of Leicester
Status
COMPLETED
Study type
OBSERVATIONAL
End Stage Kidney Disease
Start date
2021-03-01
Primary completion
2022-02-15
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.